Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Axitinib in Stage III Malignant Melanoma
NCT01321437Phase 2Completed
- Sponsor
- University of California, Irvine
- Start
- Dec 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of axitinib in Malignant Melanoma (MM), sponsored by University of California, Irvine. Started Dec 2011; status: completed.
02
Drugs
axitinib
03
Conditions
Malignant Melanoma (MM)
Beyond the preview
Go deeper on NCT01321437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01321437.